Paula Cloghessy - 07 Feb 2022 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Executive Vice President, Chief People Officer
Signature
/s//Thomas J. DesRosier, Attorney-in-Fact for Paula Cloghessy
Issuer symbol
MCRB
Transactions as of
07 Feb 2022
Net transactions value
$0
Form type
4
Filing time
08 Feb 2022, 20:35:30 UTC
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Options (right to buy) Award $0 +190,000 $0.000000 190,000 07 Feb 2022 Common Stock 190,000 $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest and become exercisable as to 25% of the shares on February 7, 2023. The remainder of the shares will vest and become exercisable in 12 equal quarterly installments thereafter.

Remarks:

Executive Vice President, Chief People Officer